Merus Announces Third Quarter 2016 Financial Results and Corporate Developments
Nov 07, 2016 12:01 pm UTC| Business
UTRECHT, The Netherlands, Nov. 07, 2016 -- Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, today announced financial results for the third...
Merus Announces Third Quarter 2016 Financial Results and Corporate Developments
Nov 07, 2016 12:01 pm UTC| Business
UTRECHT, The Netherlands, Nov. 07, 2016 -- Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, today announced financial results for the third...
Sotheby’s Reports Third Quarter 2016 Financial Results
Nov 07, 2016 12:01 pm UTC| Business
NEW YORK, Nov. 07, 2016 -- Sotheby’s (NYSE:BID) today reported its financial results for the third quarter and nine months ended 30 September 2016. For the three months ended 30 September 2016, Sotheby’s reported a...
Sotheby’s Reports Third Quarter 2016 Financial Results
Nov 07, 2016 12:01 pm UTC| Business
NEW YORK, Nov. 07, 2016 -- Sotheby’s (NYSE:BID) today reported its financial results for the third quarter and nine months ended 30 September 2016. For the three months ended 30 September 2016, Sotheby’s reported a...
Chimerix Announces Third Quarter 2016 Financial Results
Nov 07, 2016 12:00 pm UTC| Business
- Brincidofovir IV Single and Multiple Dose Data Expected to Report Out in 2017 - - Comparative Adenovirus Trial with Oral Brincidofovir Expected to Start in 2017 - - CMX521 for Norovirus Advancing Toward the Clinic - ...
Plug Power Announces 2016 Third Quarter Results
Nov 07, 2016 12:00 pm UTC| Business
LATHAM, N.Y., Nov. 07, 2016 -- Plug Power Inc. (NASDAQ:PLUG), a leader in providing energy solutions that change the way the world moves, today announced its financial results for the third quarter of 2016. Plug Power...
Heat Biologics to Present at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
Nov 07, 2016 12:00 pm UTC| Business
DURHAM, N.C., Nov. 07, 2016 -- Heat Biologics, Inc. (Nasdaq:HTBX), a leader in the development of gp96-based immunotherapies that activate a patient’s immune system to fight cancer, announced that it will present a...